.jpg)
.png)
Summer 2017
The evaluation and management of dyslipidemia has advanced in recent years. Dyslipidemia is one of the major contributors of atherosclerotic cardiovascular disease (ASCVD). According to the Centers for Disease Control and Prevention statistics, about 33.5% of adult Americans have elevated low-... more
“None of us, including me, ever do great things. But we can all do small things, with great love, and together we can do something wonderful.” – Mother Teresa A collaborative leadership has the influence to transform health-systems and healthcare organizations, improving the system today and... more
It was around 1900 when Rudolf Virchow noted that the artery walls of patients dying of occlusive vascular disease contained a yellowish fatty substance. The word chosen to describe this pathological condition was the Greek word for porridge, atheroma. This material later was identified to be... more
Since loss-of-function mutations in proprotein convertase subtilisin-kexin type 9 (PCSK9) were found to be associated with reduction in low-density lipoprotein cholesterol levels (LDL-C) and coronary events1, there has been great anticipation of the development of effective therapeutic agents to... more